Get the Stockscreener App
1.8899
1.06%
0.0199
Vivosim Labs Inc stock is traded at $1.8899, with a volume of 33,582.
It is up +1.06% in the last 24 hours and down -27.03% over the past month.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
See More
Previous Close:
$1.87
Open:
$1.86
24h Volume:
33,582
Relative Volume:
0.03
Market Cap:
$4.90M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-15.25%
1M Performance:
-27.03%
6M Performance:
-24.71%
1Y Performance:
+0.00%
1-Day Range:
$1.86
$1.9463
1-Week Range:
$1.83
$2.2299
52-Week Range:
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Name
Vivosim Labs Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
1.88 | 4.88M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.70 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
721.77 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.03 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.37 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Vivosim Labs Inc Stock (VIVS) Latest News
VIVS Earnings History & Surprises | EPS & Revenue Results | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VivoSim names Raghunathan as VP of global sales By Investing.com - Investing.com Australia
VivoSim names Raghunathan as VP of global sales - Investing.com
Vivosim appoints Arumugham (Ragoo) Raghunathan as vice president of global sales - marketscreener.com
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales - GlobeNewswire
VIVS Should I Buy - Intellectia AI
VIVS Technical Analysis & Stock Price Forecast - Intellectia AI
Exit Recap: Is VivoSim Labs Inc showing insider buying2025 Trading Volume Trends & Weekly Chart Analysis and Guides - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Travel Stocks: Does VivoSim Labs Inc have pricing powerJuly 2025 Patterns & Long-Term Capital Growth Ideas - baoquankhu1.vn
Rate Cut: Is VivoSim Labs Inc showing insider buyingQuarterly Market Review & Stock Portfolio Risk Management - baoquankhu1.vn
Sectors Review: Is SmartKem Inc part of any ETFTrade Performance Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Is VivoSim Labs Inc. benefiting from innovation trends2025 EndofYear Setup & Precise Buy Zone Identification - mfd.ru
Why VivoSim Labs Inc. stock is rated strong buyJuly 2025 Review & Risk Controlled Daily Plans - mfd.ru
Aug Fed Impact: Is LXFRs ROE strong enough2025 Market Sentiment & Stock Market Timing Techniques - baoquankhu1.vn
VIVS Income Statement | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VivoSim (VIVS) to Present Innovative Data at SOT Meeting - GuruFocus
VivoSim to Debut Antibody Drug Conjugate Data, representing - GlobeNewswire
Shorts Report: Is VivoSim Labs Inc a stock for growth or value investors2025 Big Picture & Low Drawdown Trading Techniques - baoquankhu1.vn
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego - GlobeNewswire
Sentiment Recap: What chart patterns are forming on FTNTShort Setup & Weekly Top Performers Watchlists - baoquankhu1.vn
Aug Mood: Is VivoSim Labs Inc benefiting from innovation trendsQuarterly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Aug Fed Impact: Is Quest Resource Holding Corporation attractive at current valuationJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Recap: Does VivoSim Labs Inc have pricing powerJuly 2025 Big Picture & Safe Swing Trade Setups - baoquankhu1.vn
Morning Market Movers: FATN, FIEE, TER, PBM, See Big Swings - RTTNews
Why is VIVS stock up 79% today? - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Biotech Stocks To Keep An Eye On – January 31st - Defense World
Aug PreEarnings: Is VivoSim Labs Inc showing insider buyingM&A Rumor & Reliable Entry Point Alerts - baoquankhu1.vn
Top Biotech Stocks To Follow TodayFebruary 1st - MarketBeat
VivoSim Labs Leaps 82% Amid Strategic Partnerships in Asia - StocksToTrade
Biotech Stocks To Follow Today – January 30th - Defense World
Biotech Stocks To Keep An Eye OnJanuary 31st - MarketBeat
VivoSim Labs Shares Surge 82% Amid Key Asia Distribution Deals - StocksToTrade
VivoSim Labs Stock Soars After Major Distribution Deals in Asia - timothysykes.com
Biotech Stocks To Follow TodayJanuary 30th - MarketBeat
Why Is VIVS Stock Up 79% Today? - Asianet Newsable
VivoSim Labs, Inc.Common Stock (Nasdaq:VIVS) Stock Quote - The Chronicle-Journal
Top Midday Gainers - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Gold Tumbles Over 6%; Apple Posts Upbeat Earnings - Benzinga
VivoSim Labs Expands Amid Global Market Challenges - StocksToTrade
Dow Falls Over 100 Points; Verizon Earnings Top Views - Benzinga
Morning Market Movers: TCGL, VIVS, LRHC, KXIN See Big Swings - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
VivoSim Labs stock (VIVS) jumps premarket after Korea, China distributor deals — what to watch next - TechStock²
Why SanDisk Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
VivoSim Expands Asia-Pacific Access To NAMKind Toxicology Services; Stock Skyrockets - Nasdaq
Aug Gainers: Will VivoSim Labs Inc benefit from AI trendsMarket Risk Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based - GlobeNewswire
Vivosim Labs Inc Stock (VIVS) Financials Data
There is no financial data for Vivosim Labs Inc (VIVS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):